NASDAQ: XNCRXencor Inc Stock Ownership - Who owns Xencor?
Insider buying vs selling
Have Xencor Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Nancy Valente | EVP Chief Development Officer | 2025-05-02 | 4,616 | $11.03 | $50.91kSell |
| Bart Jan Cornelissen | SR. VICE PRESIDENT CFO | 2025-04-10 | 3,750 | $8.06 | $30.23kSell |
| Nancy Valente | EVP Chief Development Officer | 2025-03-10 | 2,565 | $13.60 | $34.88kSell |
| Celia Eckert | SVP GENERAL COUNSEL | 2025-03-10 | 5,740 | $13.60 | $78.05kSell |
| John R. Desjarlais | SR. VICE PRESIDENT CSO | 2025-03-10 | 9,697 | $13.60 | $131.85kSell |
| Bassil I. Dahiyat | PRESIDENT CEO | 2025-03-10 | 19,716 | $13.60 | $268.08kSell |
| John R. Desjarlais | SR. VICE PRESIDENT CSO | 2025-02-03 | 3,542 | $15.69 | $55.57kBuy |
| Bassil I. Dahiyat | PRESIDENT CEO | 2025-02-03 | 8,808 | $15.69 | $138.20kBuy |
| Alan Bruce Montgomery | Director | 2024-12-04 | 991 | $15.35 | $15.21kBuy |
| Alan Bruce Montgomery | Director | 2024-12-04 | 430 | $20.00 | $8.60kBuy |
XNCR insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when XNCR insiders and whales buy or sell their stock.
XNCR Shareholders
What type of owners hold Xencor Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| John S. Stafford Iii | 19.05% | 13,559,817 | $124.61M | Insider |
| Blackrock Inc | 16.79% | 11,947,614 | $109.80M | Institution |
| Primecap Management Co | 13.71% | 9,761,012 | $89.70M | Institution |
| Vanguard Group Inc | 11.10% | 7,898,466 | $72.59M | Institution |
| John S. Stafford Jr. | 9.48% | 6,747,972 | $62.01M | Insider |
| Ecor1 Capital LLC | 8.63% | 6,144,767 | $56.47M | Institution |
| Ronin Capital LLC | 7.04% | 5,012,430 | $46.06M | Insider |
| Price T Rowe Associates Inc | 5.52% | 3,930,647 | $36.12M | Institution |
| State Street Corp | 5.18% | 3,683,715 | $33.85M | Institution |
| Bvf Inc | 3.85% | 2,740,141 | $25.18M | Institution |
XNCR vs Biotech Stocks
Xencor Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.